TriLink’s Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs SAN DIEGO — TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual […]

Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery. ZURICH, Switzerland – Cytosurge, the pioneer of Same-Cell Biology, announces the election of Luba Greenwood, J.D., to its Board of Directors, effective July 9, 2026. Greenwood is a […]

Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company’s SYNTAX® platform across India. Under the agreement, ILS will distribute […]

New Juno Bio lab infrastructure marks a major step in scaling provider-led care and advancing precision vaginal microbiome testing OAKLAND, Calif. — Juno Bio, a women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women’s […]

Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan’s Evercode WT services SEATTLE — Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider […]

Partners will use unprecedented data scale to advance more precise medicines to approval SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that the Billion Cell Atlas alliance has added three new member companies, including AI-native drug developer Formation Bio. As leaders in AI-driven drug discovery, design, and development, alliance members will use the unprecedented […]

BREMEN, Germany — Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH. The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples DISQVER® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker’s NGS-based […]

FREMONT, Calif. — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The new site has been renovated […]

$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO — Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month Direct-to-Phase II Small Business Innovation Research award from the National Center for Advancing Translational Sciences (NCATS), part of the […]

San Francisco, California – Yavne, Israel – Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and digital quantification, today announced the appointment of life science leader Rey Mali as its new Chief Executive Officer, with immediate effect. Rey Mali brings more […]